Document Detail


Rhabdomyolysis associated with fibrate therapy: review of 76 published cases and a new case report.
MedLine Citation:
PMID:  19756555     Owner:  NLM     Status:  In-Data-Review    
Abstract/OtherAbstract:
PURPOSE: Fibrates are used to manage mixed dyslipidemia. However, these drugs have the potential risk of inducing rhabdomyolysis. This paper gives an overview of the literature on rhabdomyolysis associated with fibrate therapy.
METHODS: We reported a case of rhabdomyolysis induced by fenofibrate and reviewed the published rhabdomyolysis cases associated with fibrate therapy.
RESULTS: Seventy-six published rhabdomyolysis cases associated with fibrates were evaluated, and a nondiabetic, nonhypertensive patient who presented with rhabdomyolysis caused by fenofibrate was reported. The onset time of the reaction varied between 36 h and 6 months. Gemfibrozil was the most frequent agent associated with rhabdomyolysis, followed by bezafibrate, fenofibrate, ciprofibrate, and clofibrate. Twenty-three cases were associated with fibrate monotherapy and 54 with fibrate therapy combined with statins or other drugs potentially interacting with fibrates. Sixteen cases had chronic renal failure before fibrate therapy, and 6 had hypothyroidism. Fifty-four complicated acute renal failure. After discontinuation of the fibrates and hydration, most patients recovered.
CONCLUSIONS: Chronic renal failure may be a risk factor for rhabdomyolysis associated with fibrates. Although rhabdomyolysis usually occurred when fibrates were combined with statins, a well-known class of agents that potentially induce rhabdomyolysis, precautions against serious adverse effects should also be taken with fibrate monotherapy.
Authors:
Jianyong Wu; Yan Song; Heng Li; Jianghua Chen
Related Documents :
15196175 - Pemphigus vulgaris induced by radiotherapy.
17616435 - Levosimendan: the inotrope of choice in cardiogenic shock secondary to takotsubo cardio...
8236465 - A prospective study of chloramphenicol induced aplastic anaemia in nigerians.
20040965 - Olanzapine induced tardive dystonia.
11981725 - Epidemiology and clinical spectrum of blastomycosis diagnosed at manitoba hospitals.
20547575 - Setting the standards for reporting ruptured abdominal aortic aneurysm.
Publication Detail:
Type:  Journal Article     Date:  2009-09-16
Journal Detail:
Title:  European journal of clinical pharmacology     Volume:  65     ISSN:  1432-1041     ISO Abbreviation:  Eur. J. Clin. Pharmacol.     Publication Date:  2009 Dec 
Date Detail:
Created Date:  2010-01-21     Completed Date:  -     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  1256165     Medline TA:  Eur J Clin Pharmacol     Country:  Germany    
Other Details:
Languages:  eng     Pagination:  1169-74     Citation Subset:  IM    
Affiliation:
Kidney Disease Center, First Affiliated Hospital, College of Medicine, Zhejiang University, 79 Qingchun Road, Hanghzou, 310003, Zhejiang, People's Republic of China.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Haptic curvature contrast in raised lines and solid shapes.
Next Document:  Drug utilisation on a preterm and neonatal intensive care unit in Germany: a prospective, cohort-bas...